Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study.

Gagneur A, Lemaître T, Gosselin V, Farrands A, Carrier N, Petit G, Valiquette L, De Wals P.

BMC Public Health. 2018 Jun 28;18(1):811. doi: 10.1186/s12889-018-5724-y.

2.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
3.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

4.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

5.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

6.

Bezlotoxumab for the prevention of Clostridium difficile recurrence.

Couture-Cossette A, Carignan A, Ilangumaran S, Valiquette L.

Expert Opin Biol Ther. 2017 Nov;17(11):1439-1445. doi: 10.1080/14712598.2017.1363886. Epub 2017 Aug 13. Review.

PMID:
28805081
7.

Update of the ICUD-SIU consultation on stone technology behind ureteroscopy.

Cloutier J, Anson K, Giusti G, Grasso M, Kamphuis G, Lahme S, Liatsikos E, Patel A, Pearle MS, Valiquette L, Traxer O.

World J Urol. 2017 Sep;35(9):1353-1359. doi: 10.1007/s00345-017-2073-x. Epub 2017 Jul 25. Review.

PMID:
28744695
8.

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Moraca S, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Vaccine. 2017 Jun 22;35(29):3647-3654. doi: 10.1016/j.vaccine.2017.05.049. Epub 2017 May 26.

9.

Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol.

Rochefort CM, Buckeridge DL, Tanguay A, Biron A, D'Aragon F, Wang S, Gallix B, Valiquette L, Audet LA, Lee TC, Jayaraman D, Petrucci B, Lefebvre P.

BMC Health Serv Res. 2017 Feb 16;17(1):147. doi: 10.1186/s12913-017-2069-7.

10.

Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay.

Nault V, Pepin J, Beaudoin M, Perron J, Moutquin JM, Valiquette L.

J Antimicrob Chemother. 2017 Mar 1;72(3):933-940. doi: 10.1093/jac/dkw468.

PMID:
27999034
11.

Energy Conservation and the Promotion of Legionella pneumophila Growth: The Probable Role of Heat Exchangers in a Nosocomial Outbreak.

Bédard E, Lévesque S, Martin P, Pinsonneault L, Paranjape K, Lalancette C, Dolcé CÉ, Villion M, Valiquette L, Faucher SP, Prévost M.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1475-1480. Epub 2016 Sep 19.

12.

Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.

Carignan A, Poulin S, Martin P, Labbé AC, Valiquette L, Al-Bachari H, Montpetit LP, Pépin J.

Am J Gastroenterol. 2016 Dec;111(12):1834-1840. doi: 10.1038/ajg.2016.417. Epub 2016 Sep 13.

PMID:
27619835
13.

Burden of Clostridium difficile Infections in Québec by Levy et al.

Longtin Y, Garenc C, Valiquette L.

Open Forum Infect Dis. 2016 Jul 1;3(3):ofw139. doi: 10.1093/ofid/ofw139. eCollection 2016 Sep. No abstract available.

14.

Delusional Infestation.

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2016;2016:9091838. doi: 10.1155/2016/9091838. Epub 2016 Mar 29.

15.

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes.

Lee C, Louie TJ, Weiss K, Valiquette L, Gerson M, Arnott W, Gorbach SL.

Can J Infect Dis Med Microbiol. 2016;2016:8048757. doi: 10.1155/2016/8048757. Epub 2016 May 24.

16.

The Effect of Obesity on Perioperative Outcomes Following Percutaneous Nephrolithotomy.

Trudeau V, Karakiewicz PI, Boehm K, Dell'Oglio P, Tian Z, Briganti A, Shariat SF, Valiquette L, Bhojani N.

J Endourol. 2016 Aug;30(8):864-70. doi: 10.1089/end.2015.0789. Epub 2016 Jun 22.

PMID:
27257037
17.
18.

Combination of Heat Shock and Enhanced Thermal Regime to Control the Growth of a Persistent Legionella pneumophila Strain.

Bédard E, Boppe I, Kouamé S, Martin P, Pinsonneault L, Valiquette L, Racine J, Prévost M.

Pathogens. 2016 Apr 15;5(2). pii: E35. doi: 10.3390/pathogens5020035.

19.

Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs.

Beaudoin M, Kabanza F, Nault V, Valiquette L.

Artif Intell Med. 2016 Mar;68:29-36. doi: 10.1016/j.artmed.2016.02.001. Epub 2016 Feb 22.

PMID:
26947174
20.

The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment.

Ballard MS, Schønheyder HC, Knudsen JD, Lyytikäinen O, Dryden M, Kennedy KJ, Valiquette L, Pinholt M, Jacobsson G, Laupland KB; International Bacteremia Surveillance Collaborative.

Infect Dis (Lond). 2016;48(5):386-91. doi: 10.3109/23744235.2015.1131330. Epub 2016 Jan 12.

PMID:
26759190
21.

Digging for new solutions.

Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):289-90. No abstract available.

22.

When it comes to stewardship, it's time to get with the programmers.

Parfitt EC, Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2015 Sep-Oct;26(5):234-6. No abstract available.

23.

Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.

Sheitoyan-Pesant C, Abou Chakra CN, Pépin J, Marcil-Héguy A, Nault V, Valiquette L.

Clin Infect Dis. 2016 Mar 1;62(5):574-580. doi: 10.1093/cid/civ958. Epub 2015 Nov 17.

PMID:
26582748
24.

Corticosteroid therapy in critical illness due to seasonal and pandemic influenza.

Yale P, Adhikari NK, Masse V, Fowler RA, Xiong W, McGeer A, Cann D, Rudnick W, Green K, Meade MO, Valiquette L, Lamontagne F.

Can Respir J. 2015 Sep-Oct;22(5):271-4.

25.

Get shorty!

Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):174-7. No abstract available.

26.

Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Abou Chakra CN, McGeer A, Labbé AC, Simor AE, Gold WL, Muller MP, Powis J, Katz K, Garneau JR, Fortier LC, Pépin J, Cadarette SM, Valiquette L.

Clin Infect Dis. 2015 Dec 15;61(12):1781-8. doi: 10.1093/cid/civ749. Epub 2015 Sep 3.

27.

The dollars and sense of chronic hepatitis C infection management.

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):119-21. No abstract available.

28.

Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.

Bettinger JA, Rouleau I, Gariepy MC, Bowie WR, Valiquette L, Vanderkooi OG, Kellner JD, Coleman BL, McNeil SA, McCarthy A, De Serres G; Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network.

Euro Surveill. 2015 Jul 23;20(29):21189.

29.

Antimicrobial shortages: Another hurdle for clinicians.

Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):67-8. No abstract available.

30.

Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis.

Baillot A, Romain AJ, Boisvert-Vigneault K, Audet M, Baillargeon JP, Dionne IJ, Valiquette L, Chakra CN, Avignon A, Langlois MF.

PLoS One. 2015 Apr 1;10(4):e0119017. doi: 10.1371/journal.pone.0119017. eCollection 2015. Review.

31.

Mycobacterium tuberculosis: 2014 Clinical trials in review.

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):11-4. No abstract available.

32.

Laboratory diagnosis of Ebola virus disease.

Martin P, Laupland KB, Frost EH, Valiquette L.

Intensive Care Med. 2015 May;41(5):895-8. doi: 10.1007/s00134-015-3671-y. Epub 2015 Jan 31. No abstract available.

PMID:
25636586
33.

A microbiological explanation for the obesity pandemic?

Valiquette L, Sirard S, Laupland K.

Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):294-5. No abstract available.

34.

Contemporary 90-day mortality rates after radical cystectomy in the elderly.

Schiffmann J, Gandaglia G, Larcher A, Sun M, Tian Z, Shariat SF, McCormack M, Valiquette L, Montorsi F, Graefen M, Saad F, Karakiewicz PI.

Eur J Surg Oncol. 2014 Dec;40(12):1738-45. doi: 10.1016/j.ejso.2014.10.004. Epub 2014 Oct 15.

PMID:
25454826
35.

Metabolic evaluation of urinary lithiasis: what urologists should know and do.

Letendre J, Cloutier J, Villa L, Valiquette L.

World J Urol. 2015 Feb;33(2):171-8. doi: 10.1007/s00345-014-1442-y. Epub 2014 Nov 21. Review.

PMID:
25414063
36.

Bill C-442: Shining the limelight on the Lyme-like?

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2014 Sep;25(5):239-40. No abstract available.

37.

The cellulitis season is open.

Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2014 Jul;25(4):184-5. No abstract available.

38.

Ebola virus disease.

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2014 May;25(3):128-9. No abstract available.

39.

Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010.

Pépin J, Abou Chakra CN, Pépin E, Nault V, Valiquette L.

PLoS One. 2014 Jun 9;9(6):e99677. doi: 10.1371/journal.pone.0099677. eCollection 2014.

40.

Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Abou Chakra CN, Pepin J, Sirard S, Valiquette L.

PLoS One. 2014 Jun 4;9(6):e98400. doi: 10.1371/journal.pone.0098400. eCollection 2014. Review. Erratum in: PLoS One. 2014;9(8):e107420.

41.

Financial impact of health care-associated infections: When money talks.

Valiquette L, Chakra CN, Laupland KB.

Can J Infect Dis Med Microbiol. 2014 Mar;25(2):71-4. No abstract available.

42.

Perceived effects of the 16-hour workday restriction on surgical specialties: Quebec's experience.

Lachance S, Latulippe JF, Valiquette L, Langlois G, Douville Y, Fried GM, Richard C.

J Surg Educ. 2014 Sep-Oct;71(5):707-15. doi: 10.1016/j.jsurg.2014.01.008. Epub 2014 May 10.

PMID:
24818538
43.

Impact of physical activity and fitness in class II and III obese individuals: a systematic review.

Baillot A, Audet M, Baillargeon JP, Dionne IJ, Valiquette L, Rosa-Fortin MM, Abou Chakra CN, Comeau E, Langlois MF.

Obes Rev. 2014 Sep;15(9):721-39. doi: 10.1111/obr.12171. Epub 2014 Apr 9. Review.

PMID:
24712685
44.

Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?

Laupland KB, Valiquette L.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):9-10. No abstract available.

45.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, Boivin G, Bowie W, Diaz-Mitoma F, Elsherif M, Green K, Haguinet F, Halperin S, Ibarguchi B, Katz K, Langley J, Lagace-Wiens P, Light B, Loeb M, McElhaney J, Mackinnon-Cameron D, McCarthy A, Poirier M, Powis J, Richardson D, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McGeer A; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network; Toronto Invasive Bacterial Diseases Network (TIBDN).

Euro Surveill. 2014 Mar 6;19(9). pii: 20729.

46.

10 years later...

Valiquette L, Laupland KB.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):175-6. No abstract available.

47.

Transmission of acute gastroenteritis and respiratory illness from children to parents.

Sacri AS, De Serres G, Quach C, Boulianne N, Valiquette L, Skowronski DM.

Pediatr Infect Dis J. 2014 Jun;33(6):583-8. doi: 10.1097/INF.0000000000000220.

PMID:
24476955
48.

Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia.

Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schønheyder HC, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Lyytikäinen O, Laupland KB; International Bacteraemia Surveillance Collaborative.

Clin Microbiol Infect. 2014 Oct;20(10):O630-2. doi: 10.1111/1469-0691.12564. Epub 2014 Feb 20.

49.

Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.

Garneau JR, Valiquette L, Fortier LC.

BMC Infect Dis. 2014 Jan 15;14:29. doi: 10.1186/1471-2334-14-29.

50.

Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec.

Bernard S, Valiquette L, De Wals P, Nault V, Babakissa C, Cyr C, Boileau TC, Gagneur A.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):138-42.

Supplemental Content

Loading ...
Support Center